Cullinan Oncology
CGEM
CGEM
148 hedge funds and large institutions have $490M invested in Cullinan Oncology in 2025 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 44 increasing their positions, 50 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
26% less call options, than puts
Call options by funds: $142K | Put options by funds: $193K
39% less capital invested
Capital invested by funds: $799M → $490M (-$309M)
44% less funds holding in top 10
Funds holding in top 10: 9 → 5 (-4)
Holders
148
Holding in Top 10
5
Calls
$142K
Puts
$193K
Top Buyers
| 1 | +$14.8M | |
| 2 | +$8.22M | |
| 3 | +$3.64M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$2.79M |
| 5 |
TCM
Tang Capital Management
San Diego,
California
|
+$1.51M |
Top Sellers
| 1 | -$12.6M | |
| 2 | -$11.1M | |
| 3 | -$8.01M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$6.14M |
| 5 |
SFAM
Springhill Fund Asset Management
Hong Kong
|
-$3.37M |
